1416489: LIDOCAINE AND PRILOCAINE,PERIODO.
LIDOCAINE AND PRILOCAINE,PERIODO. Key specifications include part_name_assigned_by_controlling_agency: ORAQIX (LIDOCAINE 2.5 PERCENT AND PRILOCAINE 2.5 PERCENT) PERIODONTAL GEL. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-656-9640, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | ORAQIX (LIDOCAINE 2.5 PERCENT AND PRILOCAINE 2.5 PERCENT) PERIODONTAL GEL |
| NSN | 6505-01-656-9640 |
| SPECIAL FEATURES | ANALGESIC AND ANESTHETIC GEL; ORAQIX (LIDOCAINE AND PRILOCAINE PERIODONTAL GEL), 2.5 PERCENT/2.5 PERCENT IS SUPPLIED IN DENTAL CARTRIDGES THAT PROVIDE 1.7G GEL; EACH GRAM OF ORAQIX CONTAINS 25-MG LIDOCAINE BASE AND 25-MG PRILOCAINE BASE; INDIVIDUALLY BLISTER-PACKAGED CARTRIDGES, OF ORAQIX ARE DISTRIBUTED IN A CARTON OF 20; EACH INDIVIDUAL BLISTER PACKAGE CONTAINS A STERILE BLUNT-TIPPED APPLICATOR; FOR SINGLE USE ONLY; NOT FOR INJECTION USE, FOR PERIODONTAL USE; STORE AT ROOM TEMPERATURE 20-25 C (68-77 F)(SEE USP CONTROLLED ROOM TEMPERATURE); AT TEMPERATURES BELOW +5 C ORAQIX MAY BECOME OPAQUE; THIS OPACITY WILL DISAPPEAR WHEN THE CARTRIDGE IS WARMED TO ROOM TEMPERATURE; DO NOT FREEZE; SOME COMPONENTS OF ORAQIX MAY PRECIPITATE IF CARTRIDGES ARE FROZEN; CARTRIDGES SHOULD NOT BE USED IF THEY CONTAIN A PRECIPITATE; DO NOT USE DENTAL CARTRIDGE WARMERS WITH ORAQIX, THE HEAT WILL CAUSE THE PRODUCT TO GEL G |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ORAQIX (LIDOCAINE 2.5 PERCENT AND PRILOCAINE 2.5 PERCENT) PERIODONTAL GEL |